SRx Health Solutions Inc. saw a sharp rally on Tuesday, with shares climbing 21% to close at approximately $0.19 on the NYSE American. The stock traded on heavy volume of 176.3 million shares, far exceeding its 46.2 million average, as investors focused on the company's strategic shift toward EMJ Crypto Technologies and digital-asset treasury management.
The stock, which trades under the ticker SRXH, moved between $0.148 and $0.2096 during the session. The surge reflects a broader transformation in the company's market perception, moving from a small pet-health stock to a proxy for a planned crypto-treasury platform. Under this model, the corporate balance sheet would hold or manage cryptocurrencies and digital assets, rather than traditional cash and short-term investments.
Deal Details and Execution Risks
The rally comes amid ongoing execution risks surrounding the all-stock EMJX deal, valued at about $55 million. The transaction still requires stockholder approvals, SEC filings, and listing approval from NYSE American for the new shares. Dilution remains a key concern, as the addition of shares would reduce each holder's stake.
Eric Jackson, a fund manager and activist investor, is expected to lead the crypto treasury firm via a reverse merger with SRx. Jackson's firm, EMJX, plans to run a multi-asset portfolio using hedging strategies, differentiating itself from rivals like Strategy Inc. Jackson has stated the goal is to "reinvest capital back into the treasury" rather than relying on dilution.
Portfolio Moves and Smartkem Stake
SRx and EMJX last week announced they had acquired a 4.99% stake in Smartkem Inc., a Nasdaq-listed advanced materials firm, through a shelf takedown and convertible preferred securities via private placement. This move is part of the company's broader strategy to build a diversified digital-asset portfolio.
On May 29, SRx and EMJX updated their portfolio, revealing a new position in Uber Technologies Inc., a reduction in their long position in Compass Inc., and a trimming of some short bitcoin bets, while adding international hedges. Michael Young from SRx's board described this as a "more cautious posture," while Jackson noted the platform is designed to "protect capital" amid potential market stress.
Financial Performance and Listing Compliance
SRx reported fiscal Q2 revenue of $3.4 million, a 23% increase year-over-year for the quarter ended March 31. Net loss improved to $6.4 million, and the company held $20.5 million in cash. CEO Kent Cunningham characterized the balance sheet as "materially strengthened" and emphasized a focus on "disciplined capital allocation."
The company remains under review by NYSE American. In January, SRx received approval for a compliance plan aimed at meeting listing standards by July 14, 2026.
Market Context and Trading Overhang
Trading overhang remains a factor, as a June prospectus supplement registered up to 187.5 million common shares for resale by selling stockholders. Another filing cited even higher potential resale tied to Keystone Capital Partners. While not all shares are guaranteed to hit the market, the overhang can weigh on sentiment when the stock moves on high volume and news.
NYSE American trades from 9:30 a.m. to 4 p.m. ET, with late trading until 8 p.m. ET. U.S. markets are set to close Friday, June 19, for Juneteenth, potentially reducing trading time this week.
